Page last updated: 2024-08-22

misonidazole and Ovarian Neoplasms

misonidazole has been researched along with Ovarian Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coombs, A; Hanson, J; Moore, JL1
Kleine, W; Ladner, HA; Nagy, D; Stange, S1
Collins, JM; Gianni, L; Greene, RF; Jenkins, JF; Lichter, AS; Myers, CE1
Ozols, RF; Poirier, MC; Reed, E; Tarone, R; Yuspa, SH1
Lichter, AS; Myers, CC; Ostechega, Y; Ozols, RF; Young, RC1

Other Studies

5 other study(ies) available for misonidazole and Ovarian Neoplasms

ArticleYear
Drug testing using a soft agar stem cell assay on patient and xenograft tumor material.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9

    Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Colony-Forming Units Assay; Drug Synergism; Etoposide; Female; Granulosa Cell Tumor; Humans; Melphalan; Methotrexate; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms; Ovarian Neoplasms; Transplantation, Heterologous; Tumor Stem Cell Assay; Vinblastine

1984
[Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
    Strahlentherapie, 1982, Volume: 158, Issue:8

    Topics: Animals; Cobalt Radioisotopes; Female; Genital Neoplasms, Female; Humans; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Ovarian Neoplasms; Radiotherapy, High-Energy; Uterine Cervical Neoplasms; Uterine Neoplasms

1982
Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Cancer research, 1983, Volume: 43, Issue:2

    Topics: Female; Humans; Injections, Intraperitoneal; Kinetics; Misonidazole; Nitroimidazoles; Ovarian Neoplasms; Radiation-Sensitizing Agents

1983
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.
    Proceedings of the National Academy of Sciences of the United States of America, 1987, Volume: 84, Issue:14

    Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; DNA Damage; DNA, Neoplasm; Drug Evaluation; Female; Humans; Middle Aged; Misonidazole; Organoplatinum Compounds; Ovarian Neoplasms

1987
The treatment of advanced stage ovarian carcinoma with a combination of chemotherapy, radiotherapy, and radiosensitizer: report of a pilot study from the National Cancer Institute.
    International journal of radiation oncology, biology, physics, 1987, Volume: 13, Issue:8

    Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Middle Aged; Misonidazole; Ovarian Neoplasms; Pilot Projects; Prognosis; Radiation-Sensitizing Agents

1987